Cargando…
A novel germline mutation of TP53 with breast cancer diagnosed as Li–Fraumeni syndrome
TP53 is a tumor suppressor gene and, when dysfunctional, it is known to be involved in the development of cancers. Li–Fraumeni syndrome (LFS) is a hereditary tumor with autosomal dominant inheritance that develops in people with germline pathogenic variants of TP53. LFS frequently develops in parall...
Autores principales: | Kai, Masaya, Kubo, Makoto, Shikada, Sawako, Hayashi, Saori, Morisaki, Takafumi, Yamada, Mai, Takao, Yuka, Shimazaki, Akiko, Harada, Yurina, Kaneshiro, Kazuhisa, Mizuuchi, Yusuke, Shindo, Koji, Nakamura, Masafumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554102/ https://www.ncbi.nlm.nih.gov/pubmed/36219266 http://dx.doi.org/10.1186/s40792-022-01546-y |
Ejemplares similares
-
Genetic medicine is accelerating in Japan
por: Hayashi, Saori, et al.
Publicado: (2022) -
Germline TP53 Mutation and Clinical Characteristics of Korean Patients With Li-Fraumeni Syndrome
por: Park, Kyoung-Jin, et al.
Publicado: (2016) -
Validity of the prognostication tool PREDICT version 2.2 in Japanese breast cancer patients
por: Zaguirre, Karen, et al.
Publicado: (2021) -
Case Report: Identification of a Novel Pathogenic Germline TP53 Variant in a Family With Li–Fraumeni Syndrome
por: Paduano, Francesco, et al.
Publicado: (2021) -
The contribution of CHEK2 to the TP53-negative Li-Fraumeni phenotype
por: Ruijs, Marielle WG, et al.
Publicado: (2009)